A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility

Differential DNA methylation panel derived from peripheral blood could serve as biomarkers of CRC susceptibility. However, most of the previous studies utilized post-diagnostic blood DNA which may be markers of disease rather than susceptibility. | A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN